News Archive

2020

March

Media Release / Mar 18, 2020

Novartis Pharmaceuticals Corporation corrective action for certain blister packages of SANDIMMUNE® and NEORAL® 100-mg soft gelatin capsules in the US due to failure to meet child-resistant packaging requirements

Read More

February

Media Release / Feb 11, 2020

Novartis announces MET inhibitor capmatinib (INC280), the first potential treatment for METex14 mutated advanced non-small cell lung cancer, granted priority FDA review

Read More

January

Media Release / Jan 16, 2020

Public-Private Collaboration Commits to Accelerate Access to Health Services in Africa, Reaching 1.7 Million People

Read More
2019

December

Media Release / Dec 11, 2019

Novartis announces FDA filing acceptance of Xolair® (omalizumab) for treatment of nasal polyps

Read More
Media Release / Dec 09, 2019

Novartis Kymriah® demonstrates consistent efficacy and safety outcomes in US patients when used in real-world setting

Read More

November

Media Release / Nov 17, 2019

Novartis PARAGON-HF analyses suggest Entresto® benefit beyond HFrEF

Read More
Media Release / Nov 15, 2019

New Novartis medicine Adakveo® (crizanlizumab-tmca) approved by FDA to reduce frequency of pain crises in individuals living with sickle cell disease

Read More
Media Release / Nov 13, 2019

Novartis launches PsO at Work with music icon Cyndi Lauper to bring to life the impact psoriasis can have in the workplace

Read More
Media Release / Nov 11, 2019

New Novartis data to be presented at American Heart Association SS2019 suggest broader clinical benefit of Entresto in chronic heart failure

Read More
Media Release / Nov 08, 2019

Novartis receives FDA approval for BEOVU®, offering wet AMD patients vision gains and greater fluid reductions vs aflibercept

Read More

Related Links